{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:17:42Z","timestamp":1791656262394,"version":"4.3.4"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00204-025-04102-3","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T12:05:29Z","timestamp":1749470729000},"page":"3877-3896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The emergence of nitazenes: a new chapter in the synthetic opioid crisis"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1769-1555","authenticated-orcid":false,"given":"Cristian","family":"Caprari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0360-8538","authenticated-orcid":false,"given":"Elena","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5295-926X","authenticated-orcid":false,"given":"Pasquale","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8888-8520","authenticated-orcid":false,"given":"Adolfo","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9210-5074","authenticated-orcid":false,"given":"Cinzia","family":"Citti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-7315","authenticated-orcid":false,"given":"Giuseppe","family":"Cannazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"4102_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196602","author":"R Ahmed","year":"2022","unstructured":"Ahmed R, Altamimi MJ, Hachem M (2022) State-of-the-art analytical approaches for illicit drug profiling in forensic investigations. Molecules. https:\/\/doi.org\/10.3390\/molecules27196602","journal-title":"Molecules"},{"key":"4102_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bph.17376","volume":"182","author":"N Alhosan","year":"2025","unstructured":"Alhosan N, Cavallo D, Santiago M, Kelly E, Henderson G (2025) Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the \u03bc-opioid receptor. Br J Pharmacol 182:969\u2013987. https:\/\/doi.org\/10.1111\/bph.17376","journal-title":"Br J Pharmacol"},{"key":"4102_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119764","volume":"561","author":"A Ameline","year":"2024","unstructured":"Ameline A, Gheddar L, Pichini S, Stove C, Aknouche F, Maruejouls C, Raul JS, Kintz P (2024) In vitro characterization of protonitazene metabolites, using human liver microsomes, and first application to two urines collected from death cases. Clin Chim Acta 561:119764. https:\/\/doi.org\/10.1016\/j.cca.2024.119764","journal-title":"Clin Chim Acta"},{"key":"4102_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2022.123767","volume":"251","author":"R Bade","year":"2023","unstructured":"Bade R, Eaglesham G, Shimko KM, Mueller J (2023) Quantification of new psychoactive substances in Australian wastewater utilising direct injection liquid chromatography coupled to tandem mass spectrometry. Talanta 251:123767. https:\/\/doi.org\/10.1016\/j.talanta.2022.123767","journal-title":"Talanta"},{"key":"4102_CR5","doi-asserted-by":"publisher","unstructured":"Bade R, Nadarajan D, Hall W, Brown J, Consortium NW, Schumann J (2024) Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis\u2014two-years of data from 22 countries. https:\/\/doi.org\/10.2139\/ssrn.4943741","DOI":"10.2139\/ssrn.4943741"},{"key":"4102_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30218-4","volume":"6","author":"Y Bao","year":"2019","unstructured":"Bao Y, Meng S, Shi J, Lu L (2019) Control of fentanyl-related substances in China. Lancet Psychiatry 6:e15. https:\/\/doi.org\/10.1016\/S2215-0366(19)30218-4","journal-title":"Lancet Psychiatry"},{"key":"4102_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0014-2999(75)90197-1","volume":"30","author":"A Barnett","year":"1975","unstructured":"Barnett A, Goldstein J, Fiedler E, Taber R (1975) Etonitazine-induced rigidity and its antagonism by centrally acting muscle relaxants. Eur J Pharmacol 30:23\u201328. https:\/\/doi.org\/10.1016\/0014-2999(75)90197-1","journal-title":"Eur J Pharmacol"},{"key":"4102_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.116054","author":"R Barone","year":"2024","unstructured":"Barone R, Pelletti G, Giorgetti A, Mohamed S, Pascali JP, Sablone S, Introna F, Pelotti S (2024) Validation and application of a method for the quantification of 137 drugs of abuse and new psychoactive substances in hair. J Pharm Biomed Anal. https:\/\/doi.org\/10.1016\/j.jpba.2024.116054","journal-title":"J Pharm Biomed Anal"},{"key":"4102_CR9","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1515\/cclm-2023-1360","volume":"62","author":"D Berardinelli","year":"2024","unstructured":"Berardinelli D, Taoussi O, Carlier J, Tini A, Zaami S, Sundermann T, Busard\u00f2 FP, Auw\u00e4rter V (2024) In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne). Clin Chem Lab Med 62:1580\u20131590. https:\/\/doi.org\/10.1515\/cclm-2023-1360","journal-title":"Clin Chem Lab Med"},{"key":"4102_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-025-01059-8","author":"JC Berger","year":"2025","unstructured":"Berger JC, Severe AD, Jalloh MS, Manini AF (2025) Naloxone dosing and hospitalization for nitazene overdose: a scoping review. J Med Toxicol. https:\/\/doi.org\/10.1007\/s13181-025-01059-8","journal-title":"J Med Toxicol"},{"key":"4102_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/dta.3113","volume":"13","author":"P Blanckaert","year":"2021","unstructured":"Blanckaert P, Balcaen M, Vanhee C, Risseeuw M, Canfyn M, Desmedt B, Van Calenbergh S, Deconinck E (2021) Analytical characterization of \u201cetonitazepyne\u201d, a new pyrrolidinyl-containing 2-benzylbenzimidazole opioid sold online. Drug Test Anal 13:1627\u20131634. https:\/\/doi.org\/10.1002\/dta.3113","journal-title":"Drug Test Anal"},{"key":"4102_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/BF01486702","volume":"36","author":"G Bromig","year":"1958","unstructured":"Bromig G (1958) \u00dcber neue starkwirkende Analgetika und ihre klinische Erprobung. Klin Wochenschr 36:960\u2013963. https:\/\/doi.org\/10.1007\/BF01486702","journal-title":"Klin Wochenschr"},{"key":"4102_CR13","unstructured":"BTNX Inc (2023) Rapid response nitazene test strips instructions product insert. strategicstrike.blob.core.windows.net\/lochness-products\/resources\/NTZ-18S26-100 (EN) Instructions-Product Insert-180.pdf. Accessed 20 February 2025)"},{"key":"4102_CR14","unstructured":"BTNX Inc (2024) Nitazene white paper 2024-03-White Paper\u2014430. strategicstrike.blob.core.windows.net\/lochness-products\/resources\/Nitazene White Paper 2024\u201303-White Paper-430.pdf. Accessed 20 February 2025"},{"key":"4102_CR15","unstructured":"BTNX | Harm Reduction (2025). BTNX | Harm Reduction. Accessed 20 February 2025"},{"key":"4102_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2024.102710","volume":"105","author":"E Buratti","year":"2024","unstructured":"Buratti E, Mietti G, Cerioni A, Cippitelli M, Froldi R, Cingolani M, Scendoni R (2024) Identification of N-piperidinyl etonitazene in alternative keratinous matrices from a decomposing cadaver. J Forensic Leg Med 105:102710. https:\/\/doi.org\/10.1016\/j.jflm.2024.102710","journal-title":"J Forensic Leg Med"},{"key":"4102_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0022-3565(25)10244-9","volume":"264","author":"ER Butelman","year":"1993","unstructured":"Butelman ER, France CP, Woods JH (1993) Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys. J Pharmacol Exp Ther 264:145\u2013151. https:\/\/doi.org\/10.1016\/S0022-3565(25)10244-9","journal-title":"J Pharmacol Exp Ther"},{"key":"4102_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF02142268","volume":"23","author":"EJA Carregal","year":"1967","unstructured":"Carregal EJA, Williams B (1967) Effects of etonitazene upon respiratory neurons. Experientia 23:57\u201359. https:\/\/doi.org\/10.1007\/BF02142268","journal-title":"Experientia"},{"key":"4102_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1021\/jm00237a024","volume":"18","author":"FI Carroll","year":"1975","unstructured":"Carroll FI, Coleman MC (1975) Etonitazene. Improved synthesis. J Med Chem 18:318\u2013320. https:\/\/doi.org\/10.1021\/jm00237a024","journal-title":"J Med Chem"},{"key":"4102_CR20","unstructured":"CFSRE (2025) NPS Opioids in the United States (Q4 2024), Trends Reports. The Center for Forensic Science Research & Education. cfsre.org\/images\/trendreports\/2024-Q4-NPS-Opioids-Trend-Report.pdf"},{"key":"4102_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052127","author":"C D\u2019Ovidio","year":"2023","unstructured":"D\u2019Ovidio C, Locatelli M, Perrucci M, Ciriolo L, Furton KG, Gazioglu I, Kabir A, Merone GM, de Grazia U, Ali I, Catena AM, Treglia M, Marsella LT, Savini F (2023) LC\u2013MS\/MS application in pharmacotoxicological field: current state and new applications. Molecules. https:\/\/doi.org\/10.3390\/molecules28052127","journal-title":"Molecules"},{"key":"4102_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109263","volume":"221","author":"MA De Luca","year":"2022","unstructured":"De Luca MA, Tocco G, Mostallino R, Laus A, Caria F, Musa A, Pintori N, Ucha M, Poza C, Ambrosio E, Di Chiara G, Castelli MP (2022) Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent \u03bc-opioid receptor agonists. Neuropharmacology 221:109263. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109263","journal-title":"Neuropharmacology"},{"key":"4102_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12954-024-01078-8","volume":"21","author":"LM De Vrieze","year":"2024","unstructured":"De Vrieze LM, Stove CP, Vandeputte MM (2024a) Nitazene test strips: a laboratory evaluation. Harm Reduct J 21:159. https:\/\/doi.org\/10.1186\/s12954-024-01078-8","journal-title":"Harm Reduct J"},{"key":"4102_CR24","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00204-024-03774-7","volume":"98","author":"LM De Vrieze","year":"2024","unstructured":"De Vrieze LM, Walton SE, Pottie E, Papsun D, Logan BK, Krotulski AJ, Stove CP, Vandeputte MM (2024b) In vitro structure\u2013activity relationships and forensic case series of emerging 2-benzylbenzimidazole \u2018nitazene\u2019 opioids. Arch Toxicol 98:2999\u20133018. https:\/\/doi.org\/10.1007\/s00204-024-03774-7","journal-title":"Arch Toxicol"},{"key":"4102_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/jat\/bkaa103","volume":"44","author":"A Di Trana","year":"2020","unstructured":"Di Trana A, Mannocchi G, Pirani F, La Maida N, Gottardi M, Pichini S, Busard\u00f2 FP (2020) A comprehensive HPLC\u2013MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid. J Anal Toxicol 44:769\u2013783. https:\/\/doi.org\/10.1093\/jat\/bkaa103","journal-title":"J Anal Toxicol"},{"key":"4102_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/jat\/bkae009","volume":"48","author":"K Diekhans","year":"2024","unstructured":"Diekhans K, Yu J, Farley M, Rodda LN (2024) Analysis of over 250 novel synthetic opioids and xylazine by LC\u2013MS-MS in blood and urine. J Anal Toxicol 48:150\u2013164. https:\/\/doi.org\/10.1093\/jat\/bkae009","journal-title":"J Anal Toxicol"},{"key":"4102_CR27","unstructured":"EMCDDA (2020) Risk Assessment 31\u2014isotonitazene\u2014report on the risk assessment of N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- Ethanamine (Isotonitazene) in accordance with article 5c of regulation (EC) no 1920\/2006 (as amended). emcdda-Risk-Assessment-Report-on-isotonitazene.pdf. Accessed 22 January 2025"},{"key":"4102_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.forc.2022.100459","author":"W Feeney","year":"2022","unstructured":"Feeney W, Moorthy AS, Sisco E (2022) Spectral trends in GC\u2013EI-MS data obtained from the SWGDRUG mass spectral library and literature: A resource for the identification of unknown compounds. Forensic Chem. https:\/\/doi.org\/10.1016\/j.forc.2022.100459","journal-title":"Forensic Chem"},{"key":"4102_CR29","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2468-2667(24)00273-1","volume":"10","author":"J Friedman","year":"2025","unstructured":"Friedman J, Ciccarone D (2025) The public health risks of counterfeit pills. Lancet Public Health 10:e58\u2013e62. https:\/\/doi.org\/10.1016\/S2468-2667(24)00273-1","journal-title":"Lancet Public Health"},{"key":"4102_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.116707","volume":"257","author":"G Gao","year":"2025","unstructured":"Gao G, Yang S, Wang X, Xiang P, Ma L, Yan F, Shi Y (2025) UHPLC\u2013MS\/MS-based analysis of 17 nitazenes in human hair for practical forensic casework with simultaneous separation of 6 groups of isomers. J Pharm Biomed Anal 257:116707. https:\/\/doi.org\/10.1016\/j.jpba.2025.116707","journal-title":"J Pharm Biomed Anal"},{"key":"4102_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00024-0","volume":"9","author":"I Giraudon","year":"2024","unstructured":"Giraudon I, Abel-Ollo K, Vanaga-Ar\u0101ja D, Heudtlass P, Griffiths P (2024) Nitazenes represent a growing threat to public health in Europe. Lancet Public Health 9:e216. https:\/\/doi.org\/10.1016\/S2468-2667(24)00024-0","journal-title":"Lancet Public Health"},{"key":"4102_CR32","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00213-023-06451-2","volume":"240","author":"GC Glatfelter","year":"2023","unstructured":"Glatfelter GC, Vandeputte MM, Chen L, Walther D, Tsai MHM, Shi L, Stove CP, Baumann MH (2023) Alkoxy chain length governs the potency of 2-benzylbenzimidazole \u2018nitazene\u2019 opioids associated with human overdose. Psychopharmacology 240:2573\u20132584. https:\/\/doi.org\/10.1007\/s00213-023-06451-2","journal-title":"Psychopharmacology"},{"key":"4102_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsir.2024.100375","volume":"10","author":"KR Gon\u00e7alves De Ara\u00fajo","year":"2024","unstructured":"Gon\u00e7alves De Ara\u00fajo KR, Fabris AL, Junior LFN, Soares AL, Costa JL, Yonamine M (2024) Synthetic illicit opioids in Brazil: Nitazenes arrival. Forensic Sci Int Rep 10:100375. https:\/\/doi.org\/10.1016\/j.fsir.2024.100375","journal-title":"Forensic Sci Int Rep"},{"key":"4102_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12954-023-00764-3","volume":"20","author":"L Gozdzialski","year":"2023","unstructured":"Gozdzialski L, Wallace B, Hore D (2023) Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations. Harm Reduct J 20:39. https:\/\/doi.org\/10.1186\/s12954-023-00764-3","journal-title":"Harm Reduct J"},{"key":"4102_CR35","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/jat\/bkac001","volume":"46","author":"A Grigoryev","year":"2023","unstructured":"Grigoryev A, Kavanagh P, Dowling G, Rodin I (2023) Tentative identification of etazene (etodesnitazene) metabolites in rat serum and urine by gas chromatography-mass spectrometry and accurate mass liquid chromatography-mass spectrometry. J Anal Toxicol 46:1032\u20131037. https:\/\/doi.org\/10.1093\/jat\/bkac001","journal-title":"J Anal Toxicol"},{"key":"4102_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF02161117","volume":"13","author":"F Gross","year":"1957","unstructured":"Gross F, Turrian H (1957) \u00dcber Benzimidazolderivate mit starker analgetischer Wirkung. Experientia 13:401\u2013403. https:\/\/doi.org\/10.1007\/BF02161117","journal-title":"Experientia"},{"key":"4102_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.forc.2024.100605","author":"EK Hardwick","year":"2024","unstructured":"Hardwick EK, Tyler Davidson J (2024) Structural characterization of nitazene analogs using electron ionization-mass spectrometry (EI-MS). Forensic Chem. https:\/\/doi.org\/10.1016\/j.forc.2024.100605","journal-title":"Forensic Chem"},{"key":"4102_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12954-017-0179-5","volume":"14","author":"L Harper","year":"2017","unstructured":"Harper L, Powell J, Pijl EM (2017) An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services. Harm Reduct J 14:52. https:\/\/doi.org\/10.1186\/s12954-017-0179-5","journal-title":"Harm Reduct J"},{"key":"4102_CR39","unstructured":"Hoffmann K, Hunger A, Kebrle J, Rossi A (1959) Verfahren zur Herstellung analgetisch wirksamer Benzimidazole. DE Patent 1057123B."},{"key":"4102_CR40","unstructured":"Hoffmann K, Hunger A, Rossi A (1960) Benzimidazoles. U.S. Patent 2935514A."},{"key":"4102_CR41","unstructured":"Homer A, Johal N (2023) Street drugs stronger than heroin linked to 54 deaths in UK [WWW Document]. BBC. https:\/\/www.bbc.com\/news\/uk-67589364. Accessed 12.3.24"},{"key":"4102_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3838","author":"B Huang","year":"2024","unstructured":"Huang B, Hua Z, Liu C, Li J, Shu JZ, Li Z (2024) Metabolism of six novel nitazenes in human liver microsomes based on ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry. Drug Test Anal. https:\/\/doi.org\/10.1002\/dta.3838","journal-title":"Drug Test Anal"},{"key":"4102_CR43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/BF02161116","volume":"13","author":"A Hunger","year":"1957","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K (1957) Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate. Experientia 13:400\u2013401. https:\/\/doi.org\/10.1007\/BF02161116","journal-title":"Experientia"},{"key":"4102_CR44","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/hlca.19600430412","volume":"43","author":"A Hunger","year":"1960","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K (1960a) Benzimidazol-derivate und verwandte Heterocyclen III. Synthese von 1-Aminoalkyl-2-nenzyl-nitro-benzimidazolen. Helv Chim Acta 43:1032\u20131046. https:\/\/doi.org\/10.1002\/hlca.19600430412","journal-title":"Helv Chim Acta"},{"key":"4102_CR45","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/hlca.19600430323","volume":"43","author":"A Hunger","year":"1960","unstructured":"Hunger A, Kebrle J, Rossi A, Hoffmann K (1960b) Benzimidazol-derivate und verwandte heterocyclen. II. Synthese von 1-Aminoalkyl-2-benzyl-benzimidazolen. Helv Chim Acta 43:800\u2013809. https:\/\/doi.org\/10.1002\/hlca.19600430323","journal-title":"Helv Chim Acta"},{"key":"4102_CR46","unstructured":"ImageJ. ImageJ. Accessed 26 February 2025."},{"key":"4102_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1434573","author":"GR Jadhav","year":"2024","unstructured":"Jadhav GR, Fasinu PS (2024) Metabolic characterization of the new benzimidazole synthetic opioids\u2014nitazenes. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1434573","journal-title":"Front Pharmacol"},{"key":"4102_CR48","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/dta.3415","volume":"15","author":"T Kanamori","year":"2023","unstructured":"Kanamori T, Okada Y, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Iwata YT (2023) Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers. Drug Test Anal 15:449\u2013457. https:\/\/doi.org\/10.1002\/dta.3415","journal-title":"Drug Test Anal"},{"key":"4102_CR49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/dta.3705","volume":"17","author":"T Kanamori","year":"2025","unstructured":"Kanamori T, Okada Y, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Iwata YT (2025) Metabolism of highly potent synthetic opioid nitazene analogs: N-ethyl-N-(1-glucuronyloxyethyl) metabolite formation and degradation to N-desethyl metabolites during enzymatic hydrolysis. Drug Test Anal 17:238\u2013249. https:\/\/doi.org\/10.1002\/dta.3705","journal-title":"Drug Test Anal"},{"key":"4102_CR50","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/add.16525","volume":"119","author":"N Killeen","year":"2024","unstructured":"Killeen N, Lakes R, Webster M, Killoran S, McNamara S, Kavanagh P, Eagleton M, McCormack S, Micheau E, Moughty A, O\u2019Donnell C, O\u2019Reilly M, Doyle G, O\u2019Rourke S, Downing S, Flynn C, Keenan E (2024) The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks. Addiction 119:1657\u20131658. https:\/\/doi.org\/10.1111\/add.16525","journal-title":"Addiction"},{"key":"4102_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3707","author":"S Killoran","year":"2024","unstructured":"Killoran S, McNamara S, Kavanagh P, O\u2019Brien J, Lakes R (2024) Identification of N-pyrrolidino protonitazene in powders sold as heroin and associated with overdose clusters in Dublin and Cork, Ireland. Drug Test Anal. https:\/\/doi.org\/10.1002\/dta.3707","journal-title":"Drug Test Anal"},{"key":"4102_CR52","doi-asserted-by":"publisher","first-page":"9577","DOI":"10.1021\/jo2019416","volume":"76","author":"Y Kim","year":"2011","unstructured":"Kim Y, Kumar MR, Park N, Heo Y, Lee S (2011) Copper-catalyzed, one-pot, three-component synthesis of benzimidazoles by condensation and C-N bond formation. J Org Chem 76:9577\u20139583. https:\/\/doi.org\/10.1021\/jo2019416","journal-title":"J Org Chem"},{"key":"4102_CR53","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/dta.3440","volume":"15","author":"MM Kimani","year":"2023","unstructured":"Kimani MM, Kern S, Lanzarotta A, Thatcher M, Lorenz LM, Smith SW, Collins M, Howe GW, Wetherby AE Jr (2023) Rapid screening of 2-benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART-TD-MS, and FT-IR. Drug Test Anal 15:539\u2013550. https:\/\/doi.org\/10.1002\/dta.3440","journal-title":"Drug Test Anal"},{"key":"4102_CR54","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/01.ftd.0000211811.27558.b5","volume":"28","author":"P Kintz","year":"2006","unstructured":"Kintz P, Villain M, Cirimele V (2006) Hair analysis for drug detection. Ther Drug Monit 28:442. https:\/\/doi.org\/10.1097\/01.ftd.0000211811.27558.b5","journal-title":"Ther Drug Monit"},{"key":"4102_CR55","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jat\/bkae050","volume":"48","author":"P Kintz","year":"2024","unstructured":"Kintz P, Ameline A, Gheddar L, Pichini S, Mazoyer C, Teston K, Aknouche F, Maruejouls C (2024) Testing for protonitazene in human hair using LC\u2013MS-MS. J Anal Toxicol 48:630\u2013635. https:\/\/doi.org\/10.1093\/jat\/bkae050","journal-title":"J Anal Toxicol"},{"key":"4102_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF02490660","volume":"50","author":"KE Kongshaug","year":"1999","unstructured":"Kongshaug KE, Pedersen-Bjergaard S, Rasmussen KE, Krogh M (1999) Solid-phase microextraction\/capillary gas chromatography for the profiling of confiscated ecstacy and amphetamine. Chromatographia 50:247\u2013252. https:\/\/doi.org\/10.1007\/BF02490660","journal-title":"Chromatographia"},{"key":"4102_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1124\/jpet.123.002052","volume":"389","author":"LB Kozell","year":"2024","unstructured":"Kozell LB, Eshleman AJ, Wolfrum KM, Swanson TL, Bloom SH, Benware S, Schmachtenberg JL, Schutzer KA, Schutzer WE, Janowsky A, Abbas AI (2024) Pharmacologic characterization of substituted nitazenes at \u03bc, \u03ba, and \u0394 opioid receptors suggests high potential for toxicity. J Pharmacol Exp Ther 389:219\u2013228. https:\/\/doi.org\/10.1124\/jpet.123.002052","journal-title":"J Pharmacol Exp Ther"},{"key":"4102_CR58","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/jat\/bkaa016","volume":"44","author":"AJ Krotulski","year":"2020","unstructured":"Krotulski AJ, Papsun DM, Kacinko SL, Logan BK (2020) Isotonitazene quantitation and metabolite discovery in authentic forensic casework. J Anal Toxicol 44:521\u2013530. https:\/\/doi.org\/10.1093\/jat\/bkaa016","journal-title":"J Anal Toxicol"},{"key":"4102_CR59","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/dta.3115","volume":"13","author":"AJ Krotulski","year":"2021","unstructured":"Krotulski AJ, Papsun DM, Walton SE, Logan BK (2021) Metonitazene in the United States\u2014forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry. Drug Test Anal 13:1697\u20131711. https:\/\/doi.org\/10.1002\/dta.3115","journal-title":"Drug Test Anal"},{"key":"4102_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114183","author":"A Lanzarotta","year":"2021","unstructured":"Lanzarotta A, Kern S, Batson J, Falconer TM, Fulcher M, Gaston KW, Kimani MM, Lorenz L, Morales-Garcia F, Ranieri N, Skelton D, Thatcher MD, Toomey VM, Voelker S, Witkowski MR (2021) Evaluation of \u201cToolkit\u201d consisting of handheld and portable analytical devices for detecting active pharmaceutical ingredients in drug products collected during a simultaneous nation-wide mail blitz. J Pharm Biomed Anal. https:\/\/doi.org\/10.1016\/j.jpba.2021.114183","journal-title":"J Pharm Biomed Anal"},{"key":"4102_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.115153","author":"A Lanzarotta","year":"2023","unstructured":"Lanzarotta A, Kern S, Batson J, Boyd B, Kimani MM, Kuo W, LaGarde D, Loh M, Adeoshun LL, Lorenz L, Melendez R, Morales-Garcia F, Thatcher M, Wetherby AE Jr, Witkowski MR (2023) Rapid detection of active pharmaceutical ingredients in drug products collected at an international mail facility by a satellite laboratory using a \u201ctoolkit\u201d consisting of a handheld Raman spectrometer, portable mass spectrometer and portable FT-IR spectrometer. J Pharm Biomed Anal. https:\/\/doi.org\/10.1016\/j.jpba.2022.115153","journal-title":"J Pharm Biomed Anal"},{"key":"4102_CR62","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/1556-4029.15537","volume":"69","author":"A Lanzarotta","year":"2024","unstructured":"Lanzarotta A, Kern S, Batson J, Collins M, Patel A, Altaf M, Arrecis J, Boyd B, Gonzalez Illan F, Griffin KM, Howe G, Hudson-Davis M, Kimani M, LaGarde D, Laguerre D, Loh M, Lorenz L, Morales-Garcia F, Sterling ME, Reimer AM, Thatcher M, Wetherby AE (2024) Analysis of unknown (unlabeled\/mislabeled) drug products for active pharmaceutical ingredients and related substances by an international mail facility satellite laboratory equipped with rapid screening devices. J Forensic Sci 69:1212\u20131221. https:\/\/doi.org\/10.1111\/1556-4029.15537","journal-title":"J Forensic Sci"},{"key":"4102_CR63","doi-asserted-by":"publisher","first-page":"107121","DOI":"10.1016\/j.isci.2023.107121","volume":"26","author":"NJ Malcolm","year":"2023","unstructured":"Malcolm NJ, Palkovic B, Sprague DJ, Calkins MM, Lanham JK, Halberstadt AL, Stucke AG, McCorvy JD (2023) Mu-opioid receptor selective superagonists produce prolonged respiratory depression. iScience 26:107121. https:\/\/doi.org\/10.1016\/j.isci.2023.107121","journal-title":"iScience"},{"key":"4102_CR64","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13033-023-00601-x","volume":"17","author":"M Meyer","year":"2023","unstructured":"Meyer M, Westenberg JN, Jang KL, Choi F, Schreiter S, Mathew N, King C, Lang UE, Vogel M, Krausz RM (2023) Shifting drug markets in North America\u2014a global crisis in the making? Int J Ment Health Syst 17:36. https:\/\/doi.org\/10.1186\/s13033-023-00601-x","journal-title":"Int J Ment Health Syst"},{"key":"4102_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.116453","author":"MC Monti","year":"2024","unstructured":"Monti MC, De Vrieze LM, Vandeputte MM, Persson M, Gr\u00e9en H, Stove CP, Schlotterbeck G (2024) Detection of N-desethyl etonitazene in a drug checking sample: chemical analysis and pharmacological characterization of a recent member of the 2-benzylbenzimidazole \u201cnitazene\u201d class. J Pharm Biomed Anal. https:\/\/doi.org\/10.1016\/j.jpba.2024.116453","journal-title":"J Pharm Biomed Anal"},{"key":"4102_CR66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13011-019-0195-4","volume":"14","author":"RB Moss","year":"2019","unstructured":"Moss RB, Carlo DJ (2019) Higher doses of naloxone are needed in the synthetic opioid era. Subst Abuse Treat Prev Policy 14:6. https:\/\/doi.org\/10.1186\/s13011-019-0195-4","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"4102_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.110686","volume":"320","author":"F Mueller","year":"2021","unstructured":"Mueller F, Bogdal C, Pfeiffer B, Andrello L, Ceschi A, Thomas A, Grata E (2021) Isotonitazene: fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland. Forensic Sci Int 320:110686. https:\/\/doi.org\/10.1016\/j.forsciint.2021.110686","journal-title":"Forensic Sci Int"},{"key":"4102_CR68","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.3390\/ijerph20064793","volume":"20","author":"A Mullin","year":"2023","unstructured":"Mullin A, Scott M, Vaccaro G, Gittins R, Ferla S, Schifano F, Guirguis A (2023) Handheld Raman spectroscopy in the first UK home office licensed pharmacist-led community drug checking service. Int J Environ Res Public Health 20:4793. https:\/\/doi.org\/10.3390\/ijerph20064793","journal-title":"Int J Environ Res Public Health"},{"key":"4102_CR69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/dta.3590","volume":"16","author":"M Murari","year":"2024","unstructured":"Murari M, Pesavento S, Greco F, Vettori A, Tagliaro F, Gottardo R (2024) Study of metabolism and potential toxicity of nine synthetic opioid analogs using the zebrafish larvae model. Drug Test Anal 16:629\u2013637. https:\/\/doi.org\/10.1002\/dta.3590","journal-title":"Drug Test Anal"},{"key":"4102_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.343036","volume":"1321","author":"D Nadarajan","year":"2024","unstructured":"Nadarajan D, O\u2019Brien J, Cresswell S, Kele B, Mueller J, Bade R (2024) Application of design of experiment for quantification of 71 new psychoactive substances in influent wastewater. Anal Chim Acta 1321:343036. https:\/\/doi.org\/10.1016\/j.aca.2024.343036","journal-title":"Anal Chim Acta"},{"key":"4102_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/PAF.0000000000000787","volume":"43","author":"DM Papsun","year":"2022","unstructured":"Papsun DM, Krotulski AJ, Logan BK (2022) Proliferation of novel synthetic opioids in postmortem investigations after core-structure scheduling for fentanyl-related substances. Am J Forensic Med Pathol 43:315. https:\/\/doi.org\/10.1097\/PAF.0000000000000787","journal-title":"Am J Forensic Med Pathol"},{"key":"4102_CR72","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/jat\/bkad062","volume":"47","author":"J Pardi","year":"2023","unstructured":"Pardi J, Ford S, Cooper G (2023) Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City. J Anal Toxicol 47:648\u2013655. https:\/\/doi.org\/10.1093\/jat\/bkad062","journal-title":"J Anal Toxicol"},{"key":"4102_CR73","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/jat\/bkae076","volume":"48","author":"C Parks","year":"2024","unstructured":"Parks C, Maskell PD, McKeown DA, Couchman L (2024) Identification of 5-aminometonitazene and 5-acetamidometonitazene in a postmortem case: are nitro-nitazenes unstable? J Anal Toxicol 48:691\u2013700. https:\/\/doi.org\/10.1093\/jat\/bkae076","journal-title":"J Anal Toxicol"},{"key":"4102_CR74","doi-asserted-by":"publisher","unstructured":"Power A, Gardner M, Andrews R, Cozier G, Kumar R, Freeman T, Blagbrough I, Scott J, Frinculescu A, Shine T, Taylor G, Norman C, Menard H, Nic Daeid N, Sutcliffe O, Husbands S, Bowman R, Haines T, Pudney C (2024) A field-portable technology for illicit drug discrimination via deep learning of hybridized reflectance\/fluorescence spectroscopic fingerprints. https:\/\/doi.org\/10.26434\/chemrxiv-2024-f5tq3-v2","DOI":"10.26434\/chemrxiv-2024-f5tq3-v2"},{"key":"4102_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/15563650.2024.2309321","volume":"62","author":"M Pucci","year":"2024","unstructured":"Pucci M, Singh Jutley G, Looms J, Ford L (2024) N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom. Clin Toxicol 62:19\u201325. https:\/\/doi.org\/10.1080\/15563650.2024.2309321","journal-title":"Clin Toxicol"},{"key":"4102_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1021\/ml200268w","volume":"3","author":"P Renton","year":"2012","unstructured":"Renton P, Green B, Maddaford S, Rakhit S, Andrews JS (2012) NOpiates: novel dual action neuronal nitric oxide synthase inhibitors with \u03bc-opioid agonist activity. ACS Med Chem Lett 3:227\u2013231. https:\/\/doi.org\/10.1021\/ml200268w","journal-title":"ACS Med Chem Lett"},{"key":"4102_CR77","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1520\/JFS13791J","volume":"40","author":"M Robertson","year":"1995","unstructured":"Robertson M, Drummer O (1995) Postmortem drug metabolism by bacteria. J Forensic Sci 40:382\u2013386. https:\/\/doi.org\/10.1520\/JFS13791J","journal-title":"J Forensic Sci"},{"key":"4102_CR78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1520\/JFS16081J","volume":"43","author":"M Robertson","year":"1998","unstructured":"Robertson M, Drummer O (1998) Stability of nitrobenzodiazepines in postmortem blood. J Forensic Sci 43:5\u20138. https:\/\/doi.org\/10.1520\/JFS16081J","journal-title":"J Forensic Sci"},{"key":"4102_CR79","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0091-3057(82)90350-1","volume":"17","author":"DB Rondeau","year":"1982","unstructured":"Rondeau DB, Turcotte M, Young L, Hebert D (1982) Similarities of the cataleptic state induced by \u03b2-endorphin and morphine. Pharmacol Biochem Behav 17:703\u2013707. https:\/\/doi.org\/10.1016\/0091-3057(82)90350-1","journal-title":"Pharmacol Biochem Behav"},{"key":"4102_CR80","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/jat\/bkad071","volume":"47","author":"M Sch\u00fcller","year":"2023","unstructured":"Sch\u00fcller M, Lucic I, \u00d8iestad \u00c5ML, Pedersen-Bjergaard S, \u00d8iestad EL (2023) High-throughput quantification of emerging \u201cnitazene\u201d benzimidazole opioid analogs by microextraction and UHPLC\u2013MS-MS. J Anal Toxicol 47:787\u2013796. https:\/\/doi.org\/10.1093\/jat\/bkad071","journal-title":"J Anal Toxicol"},{"key":"4102_CR81","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0091-3057(77)90154-X","volume":"6","author":"P Shizgal","year":"1977","unstructured":"Shizgal P, Sklar LS, Brown ZW, Amit Z (1977) Differential motor effects of intraventricular infusion of morphine and etonitazene. Pharmacol Biochem Behav 6:17\u201320. https:\/\/doi.org\/10.1016\/0091-3057(77)90154-X","journal-title":"Pharmacol Biochem Behav"},{"key":"4102_CR82","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11419-020-00552-9","volume":"39","author":"M Siczek","year":"2021","unstructured":"Siczek M, Zawadzki M, Siczek M, Ch\u0142opa\u015b-Konowa\u0142ek A, Szpot P (2021) Etazene (N, N-diethyl-2-{[(4-ethoxyphenyl)methyl]-1H-benzimidazol-1-yl}-ethan-1-amine (dihydrochloride)): a novel benzimidazole opioid NPS identified in seized material: crystal structure and spectroscopic characterization. Forensic Toxicol 39:146\u2013155. https:\/\/doi.org\/10.1007\/s11419-020-00552-9","journal-title":"Forensic Toxicol"},{"key":"4102_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.forc.2024.100594","volume":"40","author":"E Sisco","year":"2024","unstructured":"Sisco E, Appley MG, Pyfrom EM, Banta-Green CJ, Shover CL, Molina CA, Biamont B, Robinson EL (2024) Beyond fentanyl test strips: investigating other urine drug test strips for drug checking applications. Forensic Chem 40:100594. https:\/\/doi.org\/10.1016\/j.forc.2024.100594","journal-title":"Forensic Chem"},{"key":"4102_CR84","first-page":"20","volume":"9","author":"VI Sorokin","year":"1999","unstructured":"Sorokin VI (1999) Illegal synthesis of etonitazene. J Clandestine Lab Invest Chem Assoc 9:20","journal-title":"J Clandestine Lab Invest Chem Assoc"},{"key":"4102_CR85","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/10408444.2011.650790","volume":"42","author":"CP Stove","year":"2012","unstructured":"Stove CP, Ingels A-SME, De Kesel PMM, Lambert WE (2012) Dried blood spots in toxicology: from the cradle to the grave? Crit Rev Toxicol 42:230\u2013243. https:\/\/doi.org\/10.3109\/10408444.2011.650790","journal-title":"Crit Rev Toxicol"},{"key":"4102_CR86","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00204-024-03735-0","volume":"98","author":"O Taoussi","year":"2024","unstructured":"Taoussi O, Berardinelli D, Zaami S, Tavoletta F, Basile G, Kronstrand R, Auw\u00e4rter V, Busard\u00f2 FP, Carlier J (2024) Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene. Arch Toxicol 98:2101\u20132116. https:\/\/doi.org\/10.1007\/s00204-024-03735-0","journal-title":"Arch Toxicol"},{"key":"4102_CR87","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1016\/S0040-4039(97)01136-2","volume":"38","author":"JB Thomas","year":"1997","unstructured":"Thomas JB, Fall MJ, Cooper JB, Burgess JP, Carroll FI (1997) Rapid in-plate generation of benzimidazole libraries and amide formation using EEDQ. Tetrahedron Lett 38:5099\u20135102. https:\/\/doi.org\/10.1016\/S0040-4039(97)01136-2","journal-title":"Tetrahedron Lett"},{"key":"4102_CR88","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1021\/acschemneuro.1c00037","volume":"12","author":"I Ujv\u00e1ry","year":"2021","unstructured":"Ujv\u00e1ry I, Christie R, Evans-Brown M, Gallegos A, Jorge R, De Morais J, Sedefov R (2021) DARK classics in chemical neuroscience: etonitazene and related benzimidazoles. ACS Chem Neurosci 12:1072\u20131092. https:\/\/doi.org\/10.1021\/acschemneuro.1c00037","journal-title":"ACS Chem Neurosci"},{"key":"4102_CR89","unstructured":"UNODC (2024a) Drug-conventions_decisions_1961\u20132024.xlsx. Drug-conventions_decisions_1961\u20132024.xlsx. Accessed 5 March 2025"},{"key":"4102_CR90","unstructured":"UNODC (2014) Guidelines for testing drugs under international control in hair, sweat and oral fluid\u2014Manual for use by national drug analysis laboratories ST\/NAR\/30\/Rev.3. unodc.org\/documents\/scientific\/ST_NAR_30_Rev.3_Hair_Sweat_and_Oral_Fluid.pdf. Accessed 22 January 2025"},{"key":"4102_CR91","unstructured":"UNODC (2023) Recommended methods for the profiling of heroin and cocaine (revised and updated) ST\/NAR\/35\/REV. 1. Methods for Impurity Profiling of Heroin and Cocaine. Accessed 22 January 2025"},{"key":"4102_CR92","unstructured":"UNODC (2024b) World Drug Report 2024. World Drug Report 2024 Accessed 5 Marh 2025"},{"key":"4102_CR93","unstructured":"UNODC (2025) What are NPS? https:\/\/www.unodc.org\/LSS\/Page\/NPS. Accessed 5 Marh 2025"},{"key":"4102_CR94","doi-asserted-by":"publisher","unstructured":"Vaiano F, Bertol E, Mineo M, Pietrosemoli L, Rubicondo J, Supuran CT, Carta F (2021) Development of a new LC\u2013MS\/ms screening method for detection of 120 nps and 43 drugs in blood. Separations 8. https:\/\/doi.org\/10.3390\/separations8110221","DOI":"10.3390\/separations8110221"},{"key":"4102_CR95","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1021\/acschemneuro.1c00064","volume":"12","author":"MM Vandeputte","year":"2021","unstructured":"Vandeputte MM, Van Uytfanghe K, Layle NK, St. Germaine DM, Iula DM, Stove CP (2021) Synthesis, Chemical characterization, and \u03bc-opioid receptor activity assessment of the emerging group of \u201cnitazene\u201d 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci 12:1241\u20131251. https:\/\/doi.org\/10.1021\/acschemneuro.1c00064","journal-title":"ACS Chem Neurosci"},{"key":"4102_CR96","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00204-022-03276-4","volume":"96","author":"MM Vandeputte","year":"2022","unstructured":"Vandeputte MM, Krotulski AJ, Walther D, Glatfelter GC, Papsun D, Walton SE, Logan BK, Baumann MH, Stove CP (2022a) Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole \u2018nitazene\u2019 synthetic opioid. Arch Toxicol 96:1845\u20131863. https:\/\/doi.org\/10.1007\/s00204-022-03276-4","journal-title":"Arch Toxicol"},{"key":"4102_CR97","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00204-022-03294-2","volume":"96","author":"MM Vandeputte","year":"2022","unstructured":"Vandeputte MM, Verougstraete N, Walther D, Glatfelter GC, Malfliet J, Baumann MH, Verstraete AG, Stove CP (2022b) First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass. Arch Toxicol 96:1865\u20131880. https:\/\/doi.org\/10.1007\/s00204-022-03294-2","journal-title":"Arch Toxicol"},{"key":"4102_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109939","volume":"249","author":"MM Vandeputte","year":"2023","unstructured":"Vandeputte MM, Tsai M-HM, Chen L, Glatfelter GC, Walther D, Stove CP, Shi L, Baumann MH (2023) Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide. Drug Alcohol Depend 249:109939. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109939","journal-title":"Drug Alcohol Depend"},{"key":"4102_CR99","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/dta.3377","volume":"15","author":"N Verougstraete","year":"2023","unstructured":"Verougstraete N, Verhaeghe A, Germonpr\u00e9 J, Lebbinck H, Verstraete AG (2023) Identification of etazene (etodesnitazene) metabolites in human urine by LC-HRMS. Drug Test Anal 15:235\u2013239. https:\/\/doi.org\/10.1002\/dta.3377","journal-title":"Drug Test Anal"},{"key":"4102_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5555","author":"C Ververi","year":"2023","unstructured":"Ververi C, Vincenti M, Salomone A (2023) Recent advances in the detection of drugs of abuse by dried blood spots. Biomed Chromatogr. https:\/\/doi.org\/10.1002\/bmc.5555","journal-title":"Biomed Chromatogr"},{"key":"4102_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.115975","author":"C Ververi","year":"2024","unstructured":"Ververi C, Galletto M, Massano M, Alladio E, Vincenti M, Salomone A (2024) Method development for the quantification of nine nitazene analogs and brorphine in Dried Blood Spots utilizing liquid chromatography\u2014tandem mass spectrometry. J Pharm Biomed Anal. https:\/\/doi.org\/10.1016\/j.jpba.2024.115975","journal-title":"J Pharm Biomed Anal"},{"key":"4102_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212332","author":"A Vitrano","year":"2024","unstructured":"Vitrano A, Di Giorgi A, Abbate V, Basile G, La Maida N, Pichini S, Di Trana A (2024) Evaluation of short-term stability of different nitazenes psychoactive opioids in dried blood spots by liquid chromatography-high-resolution mass spectrometry. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252212332","journal-title":"Int J Mol Sci"},{"key":"4102_CR103","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jat\/bkab117","volume":"46","author":"SE Walton","year":"2022","unstructured":"Walton SE, Krotulski AJ, Logan BK (2022) A forward-thinking approach to addressing the new synthetic opioid 2-benzylbenzimidazole nitazene analogs by liquid chromatography-tandem quadrupole mass spectrometry (LC\u2013QQQ-MS). J Anal Toxicol 46:221\u2013231. https:\/\/doi.org\/10.1093\/jat\/bkab117","journal-title":"J Anal Toxicol"},{"key":"4102_CR104","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00213-022-06292-5","volume":"240","author":"SE Walton","year":"2023","unstructured":"Walton SE, Krotulski AJ, Glatfelter GC, Walther D, Logan BK, Baumann MH (2023) Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats. Psychopharmacology 240:185\u2013198. https:\/\/doi.org\/10.1007\/s00213-022-06292-5","journal-title":"Psychopharmacology"},{"key":"4102_CR105","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1039\/D3AY00766A","volume":"15","author":"SF Williams","year":"2023","unstructured":"Williams SF, Stokes R, Tang PL, Blanco-Rodriguez AM (2023) Detection & identification of hazardous narcotics and new psychoactive substances using Fourier transform infrared spectroscopy (FTIR). Anal Methods 15:3225\u20133232. https:\/\/doi.org\/10.1039\/D3AY00766A","journal-title":"Anal Methods"},{"key":"4102_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-2004-834926","volume":"2005","author":"D Yang","year":"2005","unstructured":"Yang D, Fokas D, Li J, Yu L, Baldino CM (2005) A versatile method for the synthesis of benzimidazoles from o-nitroanilines and aldehydes in one step via a reductive cyclization. Synthesis 2005:47\u201356. https:\/\/doi.org\/10.1055\/s-2004-834926","journal-title":"Synthesis"},{"key":"4102_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2023.111775","volume":"349","author":"JB Zawilska","year":"2023","unstructured":"Zawilska JB, Adamowicz P, Kurpeta M, Wojcieszak J (2023) Non-fentanyl new synthetic opioids\u2014an update. Forensic Sci Int 349:111775. https:\/\/doi.org\/10.1016\/j.forsciint.2023.111775","journal-title":"Forensic Sci Int"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04102-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04102-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:31:29Z","timestamp":1758540689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04102-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":107,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4102"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04102-3","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}